Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
7990 | 1229 | 33.8 | 61% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
330 | 17366 | FABRY DISEASE//GAUCHER DISEASE//MUCOPOLYSACCHARIDOSES |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | GALACTOSIALIDOSIS | Author keyword | 125 | 94% | 4% | 45 |
2 | GM1 GANGLIOSIDOSIS | Author keyword | 98 | 73% | 6% | 74 |
3 | SIALIDASE | Author keyword | 60 | 36% | 11% | 136 |
4 | SIALIDOSIS | Author keyword | 58 | 76% | 3% | 41 |
5 | PROTECTIVE PROTEIN CATHEPSIN A | Author keyword | 37 | 100% | 1% | 14 |
6 | NEU1 | Author keyword | 32 | 88% | 1% | 15 |
7 | MORQUIO B DISEASE | Author keyword | 31 | 92% | 1% | 12 |
8 | NEU3 | Author keyword | 31 | 92% | 1% | 12 |
9 | CATHEPSIN A | Author keyword | 25 | 66% | 2% | 23 |
10 | CANC GLYCOSYLAT | Address | 19 | 80% | 1% | 12 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | GALACTOSIALIDOSIS | 125 | 94% | 4% | 45 | Search GALACTOSIALIDOSIS | Search GALACTOSIALIDOSIS |
2 | GM1 GANGLIOSIDOSIS | 98 | 73% | 6% | 74 | Search GM1+GANGLIOSIDOSIS | Search GM1+GANGLIOSIDOSIS |
3 | SIALIDASE | 60 | 36% | 11% | 136 | Search SIALIDASE | Search SIALIDASE |
4 | SIALIDOSIS | 58 | 76% | 3% | 41 | Search SIALIDOSIS | Search SIALIDOSIS |
5 | PROTECTIVE PROTEIN CATHEPSIN A | 37 | 100% | 1% | 14 | Search PROTECTIVE+PROTEIN+CATHEPSIN+A | Search PROTECTIVE+PROTEIN+CATHEPSIN+A |
6 | NEU1 | 32 | 88% | 1% | 15 | Search NEU1 | Search NEU1 |
7 | MORQUIO B DISEASE | 31 | 92% | 1% | 12 | Search MORQUIO+B+DISEASE | Search MORQUIO+B+DISEASE |
8 | NEU3 | 31 | 92% | 1% | 12 | Search NEU3 | Search NEU3 |
9 | CATHEPSIN A | 25 | 66% | 2% | 23 | Search CATHEPSIN+A | Search CATHEPSIN+A |
10 | GLB1 | 17 | 75% | 1% | 12 | Search GLB1 | Search GLB1 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CYTOSOLIC SIALIDASE | 143 | 88% | 5% | 67 |
2 | GM1 GANGLIOSIDOSIS | 117 | 64% | 9% | 114 |
3 | APOPTOSIS SUPPRESSION | 103 | 97% | 2% | 30 |
4 | LYSOSOMAL SIALIDASE | 102 | 88% | 4% | 49 |
5 | NEURAMINIDASE DEFICIENCY | 102 | 79% | 5% | 66 |
6 | PROTECTIVE PROTEIN | 98 | 72% | 6% | 78 |
7 | GANGLIOSIDE SIALIDASE | 77 | 74% | 5% | 57 |
8 | GALACTOSIALIDOSIS | 70 | 82% | 3% | 41 |
9 | SIALIDOSIS | 65 | 76% | 4% | 45 |
10 | BETA GALACTOSIDASE DEFICIENCY | 52 | 71% | 3% | 42 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Mammalian sialidases: Physiological and pathological roles in cellular functions | 2012 | 56 | 131 | 83% |
Chaperone therapy update: Fabry disease, G(M1)-gangliosidosis and Gaucher disease | 2013 | 20 | 47 | 47% |
Lysosomal multienzyme complex: pros and cons of working together | 2014 | 4 | 94 | 60% |
GM(1) gangliosidosis: Review of clinical, molecular, and therapeutic aspects | 2008 | 54 | 61 | 80% |
Aberrant expression of sialidase and cancer progression | 2008 | 32 | 58 | 93% |
Plasma membrane-associated sialidase as a crucial regulator of transmembrane signalling | 2008 | 41 | 41 | 76% |
Desialylation of surface receptors as a new dimension in cell signaling | 2013 | 8 | 129 | 64% |
SIALIDASES IN VERTEBRATES: A FAMILY OF ENZYMES TAILORED FOR SEVERAL CELL FUNCTIONS | 2010 | 37 | 219 | 47% |
Lysosomal multienzyme complex: Biochemistry, genetics, and molecular pathophysiology | 2001 | 65 | 163 | 77% |
Where catabolism meets signalling: neuraminidase 1 as a modulator of cell receptors | 2011 | 14 | 114 | 58% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CANC GLYCOSYLAT | 19 | 80% | 1.0% | 12 |
2 | NASU DEV DISABIL | 4 | 75% | 0.2% | 3 |
3 | MOL BIOMEMBRANE GLYCOBIOL | 3 | 16% | 1.5% | 18 |
4 | PATHOCHEM NEUROCHEM | 3 | 40% | 0.5% | 6 |
5 | MED CHEM BIOCHEM BIOTECHNOL | 3 | 13% | 1.5% | 18 |
6 | BIOCHIM MALADIES METAB | 1 | 50% | 0.2% | 2 |
7 | LYSOSOMAL DISORDER WORKING GRP | 1 | 100% | 0.2% | 2 |
8 | ORIENTAL MED 591 SHIROKANE MINATO KU | 1 | 50% | 0.2% | 2 |
9 | SYNTHET ORGAN CHEM MED CHEM | 1 | 50% | 0.2% | 2 |
10 | UNIT BIOCHEM CLIN CHEM | 1 | 100% | 0.2% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000123930 | GM2 GANGLIOSIDOSIS//SANDHOFF DISEASE//TAY SACHS DISEASE |
2 | 0.0000079611 | MUCOLIPIDOSIS TYPE IV//MUCOLIPIN//MUCOLIPIDOSIS IV |
3 | 0.0000075413 | SWAINSONINE//LOCOWEED//ALPHA MANNOSIDOSIS |
4 | 0.0000072275 | PROSAPOSIN//SPHINGOLIPID ACTIVATOR PROTEIN//SAPOSIN B |
5 | 0.0000072154 | SERUM SIALIC ACID//LIPID BOUND SIALIC ACID//TOTAL SIALIC ACID |
6 | 0.0000068044 | TRANS SIALIDASE//METACYCLIC TRYPOMASTIGOTES//PREDIO INTI |
7 | 0.0000065480 | GANGLIOSIDES//GANGLIOSIDE//GM1 GANGLIOSIDE |
8 | 0.0000060996 | FUCOSIDOSIS//ALPHA L FUCOSIDASE//FUCOSE DEHYDROGENASE |
9 | 0.0000057534 | SIALYLTRANSFERASE//ST6GAL I//BETA GALACTOSIDE ALPHA 2 6 SIALYLTRANSFERASE |
10 | 0.0000057164 | ASPARTYLGLUCOSAMINURIA//GLYCOSYLASPARAGINASE//ASPARTYLGLUCOSAMINIDASE |